Genetic dissection of down syndrome-associated alterations in APP/amyloid-β biology using mouse models
Abstract Individuals who have Down syndrome (caused by trisomy of chromosome 21), have a greatly elevated risk of early-onset Alzheimer’s disease, in which amyloid-β accumulates in the brain. Amyloid-β is a product of the chromosome 21 gene APP (amyloid precursor protein) and the extra copy or ‘dose...
Enregistré dans:
Auteurs principaux: | Justin L. Tosh, Elena R. Rhymes, Paige Mumford, Heather T. Whittaker, Laura J. Pulford, Sue J. Noy, Karen Cleverley, LonDownS Consortium, Matthew C. Walker, Victor L. J. Tybulewicz, Rob C. Wykes, Elizabeth M. C. Fisher, Frances K. Wiseman |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/976af835ad394de686b40b465f483f68 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Publisher Correction: Genetic dissection of down syndrome‑associated alterations in APP/amyloid‑β biology using mouse models
par: Justin L. Tosh, et autres
Publié: (2021) -
The effects of Cstb duplication on APP/amyloid-β pathology and cathepsin B activity in a mouse model.
par: Yixing Wu, et autres
Publié: (2021) -
Dissection of the amyloid formation pathway in AL amyloidosis
par: Pamina Kazman, et autres
Publié: (2021) -
Intravenous delivery of targeted liposomes to amyloid-β pathology in APP/PSEN1 transgenic mice.
par: Eric A Tanifum, et autres
Publié: (2012) -
VIP enhances phagocytosis of fibrillar beta-amyloid by microglia and attenuates amyloid deposition in the brain of APP/PS1 mice.
par: Min Song, et autres
Publié: (2012)